全文获取类型
收费全文 | 85篇 |
免费 | 13篇 |
专业分类
化学工业 | 47篇 |
金属工艺 | 1篇 |
机械仪表 | 5篇 |
建筑科学 | 4篇 |
能源动力 | 2篇 |
轻工业 | 11篇 |
水利工程 | 1篇 |
石油天然气 | 1篇 |
无线电 | 1篇 |
一般工业技术 | 18篇 |
冶金工业 | 4篇 |
自动化技术 | 3篇 |
出版年
2024年 | 2篇 |
2023年 | 3篇 |
2022年 | 10篇 |
2021年 | 12篇 |
2020年 | 1篇 |
2019年 | 4篇 |
2018年 | 8篇 |
2017年 | 1篇 |
2016年 | 4篇 |
2015年 | 5篇 |
2014年 | 5篇 |
2013年 | 1篇 |
2012年 | 5篇 |
2011年 | 12篇 |
2010年 | 6篇 |
2009年 | 6篇 |
2008年 | 3篇 |
2007年 | 4篇 |
2006年 | 1篇 |
2003年 | 1篇 |
2002年 | 1篇 |
1997年 | 2篇 |
1996年 | 1篇 |
排序方式: 共有98条查询结果,搜索用时 46 毫秒
61.
Francesca Romana Prandi Dalgisio Lecis Federica Illuminato Marialucia Milite Roberto Celotto Stamatios Lerakis Francesco Romeo Francesco Barill 《International journal of molecular sciences》2022,23(9)
Diabetes mellitus (DM) is a glucose metabolism disorder characterized by chronic hyperglycemia resulting from a deficit of insulin production and/or action. DM affects more than 1 in 10 adults, and it is associated with an increased risk of cardiovascular morbidity and mortality. Cardiovascular disease (CVD) accounts for two thirds of the overall deaths in diabetic patients, with coronary artery disease (CAD) and ischemic cardiomyopathy as the main contributors. Hyperglycemic damage on vascular endothelial cells leading to endothelial dysfunction represents the main initiating factor in the pathogenesis of diabetic vascular complications; however, the underlying pathophysiological mechanisms are still not entirely understood. This review addresses the current knowledge on the pathophysiological links between DM and CAD with a focus on the role of epigenetic modifications, including DNA methylation, histone modifications and noncoding RNA control. Increased knowledge of epigenetic mechanisms has contributed to the development of new pharmacological treatments (“epidrugs”) with epigenetic targets, although these approaches present several challenges. Specific epigenetic biomarkers may also be used to predict or detect the development and progression of diabetes complications. Further studies on diabetes and CAD epigenetics are needed in order to identify possible new therapeutic targets and advance personalized medicine with the prediction of individual drug responses and minimization of adverse effects. 相似文献
62.
Petr Slobodian Robert Olejnik Jiri Matyas Berenika Hausnerova Pavel Riha Romana Danova Dusan Kimmer 《International journal of molecular sciences》2022,23(22)
We prepared electroactive PVDF membranes, which were subjected to mechanical as well as dual electro–mechanical signals and their responses were detected by the evoked electrical pulses. The aim was to obtain primarily electric energy that could be used for light signalling, sensing of the membrane properties and membrane motion detection. The obtained data showed the unique as well as usable properties of PVDF membranes. From this point of view, the gain and analysis of the electrical responses to combined electro–mechanical loads of PVDF membranes have been important in terms of identifying the mechanism. The detected electrical response of the PVDF membrane to their electro–mechanical pulses also indicated the possibility of using this phenomenon. Among others, it suggests monitoring of membrane fouling and use for a self-cleaning mechanism. 相似文献
63.
Emanuela Paldino Vincenza Dangelo Mariangela Massaro Cenere Ezia Guatteo Simone Barattucci Giorgia Migliorato Nicola Berretta Olaf Riess Giuseppe Sancesario Nicola Biagio Mercuri Francesca Romana Fusco 《International journal of molecular sciences》2022,23(17)
Parkinson’s disease (PD) is a neurodegenerative disease characterized by the accumulation of alpha-synuclein, encoded by the SNCA gene. The main neuropathological hallmark of PD is the degeneration of dopaminergic neurons leading to striatal dopamine depletion. Trophic support by a neurotrophin called glial-derived neurotrophic factor (GDNF) is also lacking in PD. We performed immunohistochemical studies to investigate neuropathological changes in the basal ganglia of a rat transgenic model of PD overexpressing alfa-synuclein. We observed that neuronal loss also occurs in the dorsolateral part of the striatum in the advanced stages of the disease. Moreover, along with the degeneration of the medium spiny projection neurons, we found a dramatic loss of parvalbumin interneurons. A marked decrease in GDNF, which is produced by parvalbumin interneurons, was observed in the striatum and in the substantia nigra of these animals. This confirmed the involvement of the striatum in the pathophysiology of PD and the importance of GDNF in maintaining the health of the substantia nigra. 相似文献
64.
Dino Jordanoski Damjana Drobne Nea Repar Iztok Dogsa Polona Mrak Romana Cerc-Koroec Andrijana Sever kapin Peter Nadrah Natasa Poklar Ulrih 《International journal of molecular sciences》2022,23(13)
Tetraethyl-orthosilicate (TEOS)-based nanoparticles are most extensively used as a silica-based hemoglobin carrier system. However, TEOS-based nanoparticles induce adverse effects on the hemoglobin structure. Therefore, a heulandite-calcium-based carrier was investigated as a novel silica-based hemoglobin carrier system. The heulandite-calcium mesoporous aluminosilicate particles (MSPs) were fabricated by a patented tribo-mechanical activation process, according to the manufacturer, and its structure was assessed by X-ray diffraction analysis. Upon hemoglobin encapsulation, alternation in the secondary and tertiary structure was observed. The hemoglobin-particle interactions do not cause heme degradation or decreased activity. Once encapsulated inside the particle pores, the hemoglobin shows increased thermal stability, and higher loading capacity per gram of particles (by a factor of >1.4) when compared to TEOS-based nanoparticles. Futhermore, we introduced a PEGlyted lipid bilayer which significantly decreases the premature hemoglobin release and increases the colloidal stability. The newly developed hemoglobin carrier shows no cytotoxicity to human umbilical vein endothelial cells (HUVEC). 相似文献
65.
Design of a heterogeneous enzymatic catalyst on chitosan: investigation of the role of conjugation chemistry in the catalytic activity of a Laccase from Trametes versicolor
下载免费PDF全文
66.
Romana Zahumenska Vladimir Nosal Marek Smolar Terezia Okajcekova Henrieta Skovierova Jan Strnadel Erika Halasova 《International journal of molecular sciences》2020,21(23)
One of the greatest breakthroughs of regenerative medicine in this century was the discovery of induced pluripotent stem cell (iPSC) technology in 2006 by Shinya Yamanaka. iPSCs originate from terminally differentiated somatic cells that have newly acquired the developmental capacity of self-renewal and differentiation into any cells of three germ layers. Before iPSCs can be used routinely in clinical practice, their efficacy and safety need to be rigorously tested; however, iPSCs have already become effective and fully-fledged tools for application under in vitro conditions. They are currently routinely used for disease modeling, preparation of difficult-to-access cell lines, monitoring of cellular mechanisms in micro- or macroscopic scales, drug testing and screening, genetic engineering, and many other applications. This review is a brief summary of the reprogramming process and subsequent differentiation and culture of reprogrammed cells into neural precursor cells (NPCs) in two-dimensional (2D) and three-dimensional (3D) conditions. NPCs can be used as biomedical models for neurodegenerative diseases (NDs), which are currently considered to be one of the major health problems in the human population. 相似文献
67.
Joseph A. Rothwell Pekka Keski‐Rahkonen Nivonirina Robinot Nada Assi Corinne Casagrande Mazda Jenab Pietro Ferrari Marie‐Christine Boutron‐Ruault Yahya Mahamat‐Saleh Francesca Romana Mancini Heiner Boeing Verena Katzke Tilman Kühn Katerina Niforou Antonia Trichopoulou Elisavet Valanou Vittorio Krogh Amalia Mattiello Domenico Palli Carlotta Sacerdote Rosario Tumino Augustin Scalbert 《Molecular nutrition & food research》2019,63(22)
68.
69.
Chrysostomos Charalambous Tereza Havlickova Marek Lapka Nina Puskina Romana lamberov Martin Kuchar Magdalena Sustkova-Fiserova 《International journal of molecular sciences》2021,22(5)
Cannabis/cannabinoids are widely used for recreational and therapy purposes, but their risks are largely disregarded. However, cannabinoid-associated use disorders and dependence are alarmingly increasing and an effective treatment is lacking. Recently, the growth hormone secretagogue receptor (GHSR1A) antagonism was proposed as a promising mechanism for drug addiction therapy. However, the role of GHS-R1A and its endogenous ligand ghrelin in cannabinoid abuse remains unclear. Therefore, the aim of our study was to investigate whether the GHS-R1A antagonist JMV2959 could reduce the tetrahydrocannabinol (THC)-induced conditioned place preference (CPP) and behavioral stimulation, the WIN55,212-2 intravenous self-administration (IVSA), and the tendency to relapse. Following an ongoing WIN55,212-2 self-administration, JMV2959 3 mg/kg was administered intraperitoneally 20 min before three consequent daily 120-min IVSA sessions under a fixed ratio FR1, which significantly reduced the number of the active lever-pressing, the number of infusions, and the cannabinoid intake. Pretreatment with JMV2959 suggested reduction of the WIN55,212-2-seeking/relapse-like behavior tested in rats on the twelfth day of the forced abstinence period. On the contrary, pretreatment with ghrelin significantly increased the cannabinoid IVSA as well as enhanced the relapse-like behavior. Co-administration of ghrelin with JMV2959 abolished/reduced the significant efficacy of the GHS-R1A antagonist in the cannabinoid IVSA. Pretreatment with JMV2959 significantly and dose-dependently reduced the manifestation of THC-induced CPP. The THC-CPP development was reduced after the simultaneous administration of JMV2959 with THC during conditioning. JMV2959 also significantly reduced the THC-induced behavioral stimulation in the LABORAS cage. Our findings suggest that GHS-R1A importantly participates in the rewarding/reinforcing effects of cannabinoids. 相似文献
70.
Marta Magatti Alice Masserdotti Anna Cargnoni Andrea Papait Francesca Romana Stefani Antonietta Rosa Silini Ornella Parolini 《International journal of molecular sciences》2021,22(7)
The pathophysiology of preeclampsia (PE) is poorly understood; however, there is a large body of evidence that suggests a role of immune cells in the development of PE. Amongst these, B cells are a dominant element in the pathogenesis of PE, and they have been shown to play an important role in various immune-mediated diseases, both as pro-inflammatory and regulatory cells. Perinatal cells are defined as cells from birth-associated tissues isolated from term placentas and fetal annexes and more specifically from the amniotic membrane, chorionic membrane, chorionic villi, umbilical cord (including Wharton’s jelly), the basal plate, and the amniotic fluid. They have drawn particular attention in recent years due to their ability to modulate several aspects of immunity, making them promising candidates for the prevention and treatment of various immune-mediated diseases. In this review we describe main findings regarding the multifaceted in vitro and in vivo immunomodulatory properties of perinatal cells, with a focus on B lymphocytes. Indeed, we discuss evidence on the ability of perinatal cells to inhibit B cell proliferation, impair B cell differentiation, and promote regulatory B cell formation. Therefore, the findings discussed herein unveil the possibility to modulate B cell activation and function by exploiting perinatal immunomodulatory properties, thus possibly representing a novel therapeutic strategy in PE. 相似文献